وكالة الأنباء القطرية
وكالة الأنباء القطرية
Ready to play
Ready to play
A research team at New York University has developed a simple blood test capable of detecting the earliest signs of Alzheimer's disease before the clinical symptoms of dementia appear. This is achieved through analyzing biomarkers such as "amyloid beta" and "tau" proteins. The study demonstrated a strong correlation between these markers and protein deposits in the brain, enabling precise identification of the disease's progression stages. Notably, the test can detect the disease 8 to 10 years before symptoms manifest. This technique offers early opportunities for therapeutic intervention and is less costly and easier to implement than traditional methods like positron emission tomography (PET) scans. Consequently, it enhances the potential for widespread screening and early identification of individuals at high risk.
Notice: This Is an AI-Generated Summary
Comments (0)